Company · CIK 0001178670 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Insider activity reported against this company. All insider holders · Files at: RGLS. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2026 AForm 4 → | Sep 22, 4:07 pm EDT | Yvonne GreenstreetChief Executive Officer, Director | 107 | — | — | 95,802 | — | |
| Jun 1, 2026 SForm 4 → | Jun 3, 4:25 pm EDT | David E I PyottDirector | 3,830 | $299.18 | $1,145,853 | 1,582 | −70.8% | 10b5-1 |
| Jun 1, 2026 MForm 4 → | Jun 3, 4:25 pm EDT | David E I PyottDirector | 3,830 | — | — | 5,412 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 MForm 4 → | Jun 3, 4:25 pm EDT | David E I PyottDirector | 3,830 | — | — | 0 | — | 10b5-1 |
| Jun 1, 2026 AForm 4 → | Jun 3, 4:23 pm EDT | Benjamin CravattDirector | 4,393 | — | — | 4,393 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.